Coya Therapeutics (COYA) Assets Average (2023 - 2026)

Coya Therapeutics (COYA) has 4 years of Assets Average data on file, last reported at $51.6 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average rose 24.74% year-over-year to $51.6 million; the trailing twelve-month figure through Mar 2026 stood at $51.6 million (up 24.74% YoY), and the FY2025 full-year result was $47.1 million, up 10.15% from the prior year.
• Assets Average advanced to $51.6 million in Q1 2026, from $41.0 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $51.6 million in Q1 2026 to a low of $12.9 million in Q1 2023.
• A 4-year average of $32.8 million and a median of $37.7 million in 2024 frame the typical range for Assets Average.
• Across the five-year window, Assets Average soared 204.7% in 2024 and retreated 13.24% in 2025, its largest moves.
• Tracing COYA's Assets Average over 4 years: stood at $26.6 million in 2023, then soared by 50.31% to $39.9 million in 2024, then rose by 2.62% to $41.0 million in 2025, then increased by 25.89% to $51.6 million in 2026.
• Business Quant data shows COYA's Assets Average at $51.6 million in Q1 2026, $41.0 million in Q4 2025, and $32.7 million in Q3 2025.